FPF
CLVS

FNY Partners Fund’s Clovis Oncology, Inc. CLVS Stock Holding History

FNY Partners Fund’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-40
Closed -$3K – 651
2017
Q3 		$3K Buy
+40
New +$3.17K ﹤0.01% 488
2017
Q2 		– Sell
-25
Closed -$1K – 1269
2017
Q1 		$1K Buy
25
+10
+67% +$608 ﹤0.01% 1367
2016
Q4 		$1K Buy
+15
New +$528 ﹤0.01% 569

Other funds holding CLVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PC
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $7.71B AUM 4.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

FNY Partners Fund's CLVS Position: Q1 2018 in Review

FNY Partners Fund increased its Clovis Oncology, Inc. (CLVS) stake by 140% in Q1 2018, buying an estimated $40.8K and bringing the position to 1,200 shares worth $63K. The position accounts for 0.03% of the portfolio, ranked #163.

FNY Partners Fund first reported a position in CLVS in Q2 2017 and has held it in 3 quarters since. The position peaked at $374K in Q2 2017. 229 funds tracked by Wall St. Rank hold CLVS as of Q1 2018.

  • FNY Partners Fund held 1,200 shares of Clovis Oncology, Inc. worth $63K as of Q1 2018.
  • FNY Partners Fund bought 700 Clovis Oncology, Inc. shares in Q1 2018, an estimated $40.8K.
  • Clovis Oncology, Inc. made up 0.03% of FNY Partners Fund's portfolio in Q1 2018, its #163 holding.
  • FNY Partners Fund first reported a position in Clovis Oncology, Inc. in Q2 2017 and has held it in 3 quarters since.
  • FNY Partners Fund's Clovis Oncology, Inc. position peaked at $374K in Q2 2017.
  • 229 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q1 2018.

Based on FNY Partners Fund's 13F filing for Q1 2018, filed 18 Apr 2018.